Skip to main content
Premium Trial:

Request an Annual Quote

Interleukin Genetics Q1 Revenues Drop 17 Percent

NEW YORK (GenomeWeb) – Interleukin Genetics today reported that its first quarter revenues fell 17 percent year over year on lower genetic testing service revenue.

The Waltham, Massachusetts-based genetic testing firm reported total revenues of $403,212 for the three months ended March 31 compared to $487,566 for the first quarter of 2014. Its genetic testing service revenue declined to $347,900 from $420,333 year over year, which the firm attributed to a decrease in genetic test kits returned for processing from a promotional product bundle program.

The firm's "other" revenue was $55,312 for the quarter, down from $67,233 in Q1 2014.

Interleukin posted a net loss of $1.8 million, or $.01 per share, for Q1 2015, compared to a loss of $1.7 million, or $.01 per share, for the first quarter of 2014.

Its R&D spending fell to $182,530 from $209,176 year over year, while its SG&A expenses were slightly higher at $1.6 million versus $1.5 million.

"Interleukin Genetics' highest priority in the coming months is to maximize the commercial potential of PerioPredict, our genetics-based risk assessment test for severe periodontitis," Interleukin CEO Mark Carbeau said in a statement, adding that the firm's recent alliance with Employee Benefit Consulting Group is a "key element of our strategy."

Carbeau was named the new CEO of Interleukin last month.

Interleukin finished the quarter with $9.6 million in cash and cash equivalents, which it said was enough to fund operations for at least the next 12 months.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.